THE WHAT, WHY AND HOW OF BAYESIAN CLINICAL-TRIALS MONITORING - DISCUSSION

被引：3

作者：

MACHIN, D

机构：

[1] MRC Cancer Trials Office, Cambridge, CB2 2BQ

来源：

STATISTICS IN MEDICINE | 1994年 / 13卷 / 13-14期

关键词：

D O I：

10.1002/sim.4780131313

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

[No abstract available]

引用

页码：1385 / 1389

页数：5

共 17 条

[1]

[Anonymous], 1992, DESIGN ANAL SEQUENTI

[2] INTERIM ANALYSIS OF FAILURE TIME DATA - A BAYESIAN-APPROACH [J].

BARTOLUCCI, AA ;

KATHOLI, CR ;

BIRCH, R .

ENVIRONMETRICS, 1992, 3 (04) :465-477

[3] A SIMULATED SEQUENTIAL-ANALYSIS BASED ON DATA FROM 2 MRC TRIALS [J].

DONALDSON, AN ;

WHITEHEAD, J ;

STEPHENS, R ;

MACHIN, D .

BRITISH JOURNAL OF CANCER, 1993, 68 (06) :1171-1178

[4] TOWARDS AN INTERNATIONAL REGISTER OF CANCER TRIALS - THE UKCCCR REGISTER OF UK TRIALS [J].

FAYERS, PM ;

ARMITAGE, T .

EUROPEAN JOURNAL OF CANCER, 1993, 29A (06) :907-912

[5]

FAYERS PM, IN PRESS STATISTICS

[6]

Freedman L, 1983, STATISTICIAN, V32, P153

[7] STOPPING RULES FOR CLINICAL-TRIALS INCORPORATING CLINICAL OPINION [J].

FREEDMAN, LS ;

LOWE, D ;

MACASKILL, P .

BIOMETRICS, 1984, 40 (03) :575-586

[8]

FREEDMAN LS, 1994, STATISTICS MED, V13

[9] PLANNING SIZE AND DURATION OF A CLINICAL TRIAL STUDYING TIME TO SOME CRITICAL EVENT [J].

GEORGE, SL ;

DESU, MM .

JOURNAL OF CHRONIC DISEASES, 1974, 27 (1-2) :15-24

[10]

MACHIN D, 1992, INTRODUCING NEW TREA

← 1 2 →